Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Unknown 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Infections 2

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Antibiotic Prophylaxis × Clear all
NCT04815876 2026-02-20

PREVENT2

Weill Medical College of Cornell University

Phase NA Completed
1,030 enrolled
Genitourinary

Infections, Prostatic Neoplasms

NCT04843566 2025-04-15

PREVENT

Weill Medical College of Cornell University

Phase NA Completed
687 enrolled 11 charts
Genitourinary

Infections, Prostatic Neoplasms

NCT04146142 2021-12-07

NORAPP

Oslo University Hospital

Phase NA Completed
550 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡